Search
for
Sort by
Research 30 of 1000+
- Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women’s cancers. Results of a prospective study
- The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B‐rapidly accelerated fibrosarcoma‐mutated advanced melanoma
- Dermatological adverse events with taxane chemotherapy
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Cutaneous Drug Reaction Case Reports
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- Dermatologic Care of the Transplant Patient
- Index
- Cutaneous drug reactions
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion
- Mucocutaneous findings in hematolymphoid neoplasms: An observational study
- Mucocutaneous reactions to chemotherapy
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- Dermatologic Adverse Events from Cancer Treatments
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Mucocutaneous Side Effects of Antineoplastic Drugs Used in Cancer Therapy in Erbil
- Skin manifestations associated with COVID-19
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Regulation of Keratin 9 in Nonpalmoplantar Keratinocytes by Palmoplantar Fibroblasts Through Epithelial–Mesenchymal Interactions
- Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
- Recessive Mutation in FAM83G Associated with Palmoplantar Keratoderma and Exuberant Scalp Hair